In 2009, the number of fattening pigs was over 640 million, that of flattening cattle over 40 million, and that of flattening poultries over 11 billion in China. In addition, large numbers of poultry eggs and over 12 million dairy cows were cultivated. In China, the breeding stock and fattened stock of pigs, cattle, sheep and other major domesticated animals essentially remain the growth rate of over 5%. It follows that the farmed animals requiring massive immunization are in huge number.
As the production of Chinese animal husbandry is changed from scattered mode to intensive and unified prevention mode, China is rapidly developing in the biological product industry based on veterinary vaccines. Currently, domestic veterinary vaccines are divided into FMD (Foot and mouth, abbr. FMD) vaccines, influenza vaccines, PRRS(Porcine Reproductive and Respiratory Syndrome, abbr. PRRS) vaccines, etc. As to the biotechnology, vaccines are divided into W vaccines, inactivated vaccines, live vaccines, influenza vaccines, etc.
In China, the animal vaccine industry is regarded as the gold mine of the capital market. The reason why the animal vaccine industry is expected lies in the large number of immune animals, far exceeding that of immune people; among up to hundreds of species of animal diseases, 70% are co-infected by human and animals-; the diseases spread more easily after the large-scale farming is improved, which raises the demand for vaccines; national subsidies and appropriation continue increasing; polyvalent vaccines replace the product up-gradation of monovalent vaccines; new products like pet vaccines amplify the vaccine market.
In 2009, the scale of China’s animal vaccine market was about CNY4.50 billion (USD740 million), increasing by more than 40% over 2008. It is predicted that in the next few years China’s vaccine industry will maintain a growth rate of 20-30% per year.
In general, with years of development of China’s veterinary vaccines, a relatively complete vaccine engineering system with complete vaccine product varieties has been formed. China, as one of the best stock farming countries, sees an increasing number of raised domestic animals, which has brought a greater rate of growth in the R&D of veterinary vaccines. With the increase of the intensification of livestock rearing, the vaccines related to diseases of respiratory tract, gastrointestinal tract and reproductive system have always been the focus of economic veterinary vaccines. With the increase of the intensification of livestock rearing and people's concern about food safety, the veterinary vaccine market will continue the steady growth trend.
This report has acquired a lot of valuable first-hand information through interviews and other means, and has quoted rich secondary sources of the Chinese Customs, trade associations, etc.
The following and more information can be acquired from this report:
- Government policy environment of Chinese animal vaccines
- Current situation of China’s animal vaccine market
- Current situation of China’s animal vaccine technology
- China's import and export situation of animal vaccines
- The development of China’s animal vaccine sub-industries
- Major enterprises of China’s animal vaccine industry and their operations
- Competition in China’s animal vaccine market
- Prospects for the development of China’s animal vaccine industry
The following persons are advised to buy this report:
- Animal vaccine manufacturers
- Animal vaccines trading enterprises
- Farming enterprises
- Animal vaccine research institutions
- Investors focusing on China's animal vaccine industry
To get more details, please go to http://www.cri-
# # #
The primary and secondary research was conducted by consultants in China who know the industry and the local markets well.